Q-omics provides the consensus-scored USP17L22 profile across patient tissues and cancer cell-line models. Additionally, USP17L22 RNA expression shows 45 significant pathway-activity associations, with the highest sampling consensus in OV.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for USP17L22 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with USP17L22 in patient tissues and cancer cell lines. In patient samples, USP17L22 shows the broadest associations at the RNA and protein expression levels, with OV recurring as the lineage with the largest associated feature set. In cancer cell lines, USP17L22 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in PANCREAS, while CRISPR and shRNA rows add functional-dependency signals in UPPER_AERODIGESTIVE_TRACT.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	45	OV (45)	view →
RNA	15	OV (15)	view →

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	278	PANCREAS (169)	view →
Mutation	114	UPPER_AERODIGESTIVE_TRACT (69)	view →